Friday, October 9, 2015: 12:30 PM-2:00 PM
Room: Poster Hall
Learning Objectives:
-
Tracks: Investigative ID
Presentations:
Clinical use of a prediction rule to guide admission policy in community-acquired invasive urinary tract infection: a randomized clinical trial
J.E. Stalenhoef, MD
;
C. Van Nieuwkoop, MD, PhD
;
A.M. Vollaard, MD, PhD
;
W.E. Van Der Starre, MD
;
N.M. Delfos, MD
;
E.M.S. Leyten, MD, PhD
;
T. Koster, MD, PhD
;
H.C. Ablij, MD
;
J.W. Van 't Wout, MD, PhD
;
J.T. Van Dissel, MD, PhD
Effectiveness of Implementing Take-Home Kits for Specimen Collection in a Clinical Trial
Jenna Los, MLA
;
Mary Bessesen, MD
;
Alexandria C Brown, PhD
;
Derek Cummings, PhD
;
Charlotte Gaydos, DrPH, FIDSA
;
Cynthia Gibert, MD, MSc, FIDSA
;
Geoffrey Gorse, MD, FIDSA
;
Jeffrey Holden, MA
;
Ann-Christine Nyquist, MD, MSPH, FPIDS
;
Connie S. Price, MD
;
Lewis J. Radonovich, MD
;
Nicholas G Reich, PhD
;
Maria C. Rodriguez-Barradas, MD, FIDSA
;
Michael S. Simberkoff, MD, FIDSA
;
Trish M. Perl, MD, MSc, FIDSA, FSHEA
Characterization of Mycoplasma pneumoniae Infection and Outcomes in the SOLITAIRE-Oral, Global Phase 3 Clinical Trial for Solithromycin
David Oldach, MD, FIDSA
;
Hristo Metev, MD
;
Analia Mykietiuk, MD
;
Cristina Mihaela Tanaseanu, MD
;
Anita Das, PhD
;
Brian Jamieson, MD
;
Kay Clark, RN
;
Amanda Sheets, PhD
;
Kara Keedy, PhD
;
Donna Crabb, MT(ASCP)
;
Amy Ratliff, MLS (ASCP)
;
Ken Waites, MD
;
Prabhavathi Fernandes, PhD
Detection of Pneumococcal Pneumonia in a Phase 3 Trial Comparing Oral Solithromycin versus Oral Moxifloxacin for Treatment of Community-acquired Bacterial Pneumonia in Adults
Sopio Chochua, MD, PhD, MSCR
;
Amanda Sheets, PhD
;
Kara Keedy, PhD
;
Brian Jamieson, MD
;
David Oldach, MD, FIDSA
;
Prabhavathi Fernandes, PhD
;
Anita Das, PhD
;
Keith Klugman, MD, PhD, FIDSA
;
Jorge Vidal, PhD
Does Rifaximin Chemoprophylaxis Prevent Campylobacteriosis in the Human Challenge Model?
Clayton D. Harro, MD, ScM
;
Joanna E. Rimmer, MBChB, DTM&H
;
David Sack, MD
;
Kawsar R. Talaat, MD
;
Ramiro L. Gutierrez, MD, MPH
;
Barbara Denearing, RN, BSN, CCRC
;
Chad K. Porter, Ph.D., MPH
;
Jessica Brubaker, M.S.
;
Alexander C. Maue, Ph.D.
;
Renee M. Laird, Ph.D.
;
Frederic Poly, Ph.D.
;
Patricia Guerry, Ph.D.
;
Kayla Jaep, B.S.
;
Ashley Alcala, B.S.
;
David R. Tribble, MD, DrPH, FIDSA
;
Mark S. Riddle, MD, DrPH
GEN-003 Phase 2 Interim Results: Therapeutic Vaccine for Genital Herpes Significantly Reduces Viral Shedding and Genital Lesions
Nicholas Van Wagoner, MD, PhD
;
William Koltun, MD
;
Gregg Lucksinger, MD
;
Terri Warren, ANP
;
Stephen Tyring, MD, PhD, FIDSA
;
David Bernstein, MD, FIDSA
;
Peter Leone, MD
;
Lori Panther, MD, MPH
;
Jacob Lalezari, MD
;
Kenneth Fife, MD, PhD, FIDSA
;
Richard Novak, MD
;
Richard Beigi, MD, MSc.
;
John Kriesel, MD
;
Jason Chan, PhD
;
Sybil Tasker, MD, FIDSA
;
Seth Hetherington, MD
;
Anna Wald, MD, MPH, FIDSA
A Phase I Safety and Immunogenicity Dose Escalation Trial of Plague Vaccine, Flagellin/F1/V, In Healthy Adult Volunteers (DMID 08-0066)
Sharon E Frey, MD
;
Kathleen Lottenbach, MS
;
Irene Graham, MD
;
Edwin Anderson, MD
;
Kanwaldeep Bajwa, MPH
;
Ryan May, PhD
;
Steven B Mizel, PhD
;
Aaron H Graff, BS
;
Robert B Belshe, MD
A Prospective Phase 3 Trial of Boceprevir/Pegylated Interferon/Ribavirin for HCV/HIV Coinfected Persons
Kenneth Sherman, MD
;
Minhee Kang, MS, PhD
;
Richard Sterling, MD
;
Triin Umbleja, MSc
;
Kristen M. Marks, MD
;
Beverly Alston-Smith, MD
;
Wayne Greaves, MD
;
Adeel Butt, MD, MS
Early Innate and Adaptive Immune Responses to Investigational Human Immunodeficiency Virus (HIV)-1 Vaccines (VRC 016 study)
Uzma Sarwar, MD
;
Laura Novik, RN
;
Mary Enama, M.A., PA-C
;
Douglas Herrin, B.S.
;
Sandeep Narpala, M.S.
;
Adrian Mcdermott, M.Sc., PhD
;
Barney S. Graham, MD, PhD, FIDSA
;
Julie Ledgerwood, D.O.
Atazanavir plus Cobicistat (ATV+c) versus Atazanavir plus Ritonavir (ATV+r), Both in Combination with Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): Week 48 Subgroup Analysis of a Phase 3, Randomized, Double-Blind, Active-Controlled Trial
Edwin Dejesus, MD, FACP, FIDSA
;
Joel Gallant, MD, MPH, FIDSA
;
Peter Shalit, MD, PhD
;
Huyen Cao, MD
;
Ya-Pei Liu, PhD
;
Joel Myers, MPharm
;
Lisa Rosenblatt, MD, MPH
;
Lingfeng Yang, PhD, MPH
;
Javier Szwarcberg, MD, MPH
The Use of Home-Based Telepsychiatry for Mild to Moderate Major Depression in HIV-Positive Adults 50 Years and Older Living in San Francisco
Jessica Rhee, BA
;
Eric Chan, MD
;
Paul Elizondo III, DO
;
James Bourgeois, OD, MD
;
Cameron Foreman, BA
;
Lisa Dazols, LCSW
;
Jorien Breur, MD
;
Joseph Shemuel, BA
;
Amanda Martin, MSW
;
Sharonya Shrivastava, BA
;
Malcolm John, MD, MPH
Stable caloric intake and continued virologic suppression for HIV positive antiretroviral treatment (ART) experienced women after switching to fixed dose combination (FDC) of Emtricitabine (FTC), Tenofovir (TDF) and Rilpivirine (RPV)
Prema Menezes, Ph D
;
Katie Mollan, MS
;
Erin Hoffman, BS
;
Parker Xie, BS
;
Jennifer Wills, RDN
;
Cheryl Marcus, MSN
;
John Rublein, pharm d
;
Michael G. Hudgens, PhD
;
Joseph Eron, MD
CME Credits:
ACPE Credits:
ACPE Number:
